Drug Shortage Report for MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL
Report ID | 23172 |
Drug Identification Number | 02443902 |
Brand name | MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL |
Common or Proper name | EMTRICITABINE/TENOFOVIR DISOPROXIL |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE |
Strength(s) | 300MG 200MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30BT |
ATC code | J05AR |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-12-19 |
Actual start date | |
Estimated end date | 2019-01-11 |
Actual end date | 2018-12-18 |
Shortage status | Avoided shortage |
Updated date | 2018-12-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v76 | 2018-10-09 | French | Compare |
v75 | 2018-10-09 | English | Compare |
v74 | 2018-09-24 | French | Compare |
v73 | 2018-09-24 | English | Compare |
v72 | 2018-09-17 | French | Compare |
v71 | 2018-09-17 | English | Compare |
v70 | 2018-09-10 | French | Compare |
v69 | 2018-09-10 | English | Compare |
v68 | 2018-08-21 | French | Compare |
v67 | 2018-08-21 | English | Compare |
v66 | 2018-06-25 | French | Compare |
v65 | 2018-06-25 | English | Compare |
v64 | 2018-06-05 | French | Compare |
v63 | 2018-06-05 | English | Compare |
v62 | 2018-05-08 | English | Compare |
v61 | 2018-05-04 | French | Compare |
v60 | 2018-05-04 | English | Compare |
v59 | 2018-05-04 | English | Compare |
v58 | 2018-05-03 | French | Compare |
v57 | 2018-05-03 | English | Compare |